Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-22T21:08:01.986Z Has data issue: false hasContentIssue false

Risperidone-induced leucopenia and neutropenia: a case report

Published online by Cambridge University Press:  16 April 2020

Myrthe Sluys
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
Yener Güzelcan*
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
Gerty Casteelen
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
Lieuwe de Haan
Affiliation:
Department of Psychiatry, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands
*
*Corresponding author. E-mail address: [email protected] (Y. Güzelcan).
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Case report
Copyright
Copyright © 2004 European Psychiatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mahmood, TSilverstone, TSpittle, B.Risperidone appears to be safe in patients with antipsychotic-induced blood dyscrasias. Int Clin Psy-chopharmacol 1996;11:53–4.CrossRefGoogle ScholarPubMed
Dernovsek, ZTavcar, RRisperidone-induced leucopenia and neutro-penia. Br J Psychiatry 1997;171:393–4.CrossRefGoogle Scholar
Finkel, BLerner, AGOyffe, ISigal, MRisperidone-associated agranulocytosis. Am J Psychiatry 1998;155:6.Google ScholarPubMed
Bondolfi, GMorena, PDascal, DBertschy, GRisperidone and reversible neutropenia: a negative rechallenge. Eur Neuropsychopharmacol 1996;6:257.CrossRefGoogle ScholarPubMed
Hong, XWang, XAgranulocytosis and neutropenia with typical and atypical neuroleptics. Am J Psychiatry 2001;158:1736–7.CrossRefGoogle ScholarPubMed
Godleski, LSSernyak, MJAgranulocytosis after addition of risperi-done to clozapine treatment. Am J Psychiatry 1996;153:735–6.Google Scholar
Submit a response

Comments

No Comments have been published for this article.